Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors

Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors

US Patent 9151743 · Granted Oct 6, 2015

Estimated economic value: $60,848,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for t2025
ADAMTS binding immunoglobulins2025
Polypeptides binding ADAMTS5, MMP13 and aggrecan2023
ADAMTS binding immunoglobulins2022
Cyclic amides as MetAP-2 inhibitors2018
Pyrrolidinone derivatives as MetAP-2 inhibitors2018
Imidazo[4,5-C]quinolines as DNA-PK inhibitors2017
7-azaindole-2,7-naphthyridine derivative for the treatment of tumours2016
Morpholinylquinazolines2015
Bipyridyl derivatives2015
Pyrido [2, 3-B] pyrazine compounds and their therapeutical uses such as for inhi2015
Imidazo[4,5-c]quinolines as DNA-PK inhibitors2015